Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-10-08, the close was $81.76: 7.9% below the 50-day average and 3.8% below the 200-day average, which is rising. RSI (14) is 32, in its neutral range. MACD is bearish. The stock sits 46% of the way up its 52-week range of $65.31 to $100.98, on 1.1x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $88.80 | Price 7.9% below |
| 200-day average | $84.96 | Price 3.8% below, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 32 | Neutral range |
| MACD (12, 26, 9) | -2.21 vs -1.80 | Line below signal |
| 52-week range | $65.31 to $100.98 | 46% of the way up the range |
| Volume vs 20-day average | 1.1x | Normal |
Base rates use VTR's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-08, VTR's 14-day RSI is 32, which is in the neutral range between 30 and 70.
No. VTR closed at $81.76 on 2026-10-08, 3.8% below its 200-day average of $84.96, which is rising. When it closed below its 200-day average (1,739 days), it was higher 63 trading days later 70% of the time, median +7.6%.
No. VTR closed at $81.76 on 2026-10-08, 7.9% below its 50-day average of $88.80. When it closed below its 50-day average (2,385 days), it was higher 63 trading days later 67% of the time, median +6.4%.
No cross in the last 10 trading days. As of 2026-10-08 the MACD line is -2.21 against a signal line of -1.80, so MACD is bearish.
No. At $81.76 it sits 46% of the way up its 52-week range of $65.31 to $100.98, 19.0% below the high.
Leaning bearish: 1 of 5 indicators are bullish and 3 bearish as of 2026-10-08 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Buy, from the chart signal model.
VTR analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.